CA Patent

CA2763040C — Methods and compositions for the treatment of cancer

Assigned to Individual · Expires 2018-05-01 · 8y expired

What this patent protects

The instant invention provides methods and compositions for the treatment and prevention of cell proliferative disorders.

USPTO Abstract

The instant invention provides methods and compositions for the treatment and prevention of cell proliferative disorders.

Drugs covered by this patent

chembl-chembl428647 (PACLITAXEL)

Patent Metadata

Patent number: CA2763040C
Jurisdiction: CA
Classification: —
Expires: 2018-05-01
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.